Macrophages exist throughout the body as resident components of most tissues. They are embryonically derived, seeded into tissues in utero and maintained by in situ proliferation 1,2 . During inflammation, additional macrophages develop from monocytes recruited from the bone marrow 1 or from the proliferation of resident cells 3 . Macrophages are crucial for immunity and can adopt different activation states depending on the context. Interferon-γ (IFN-γ) in combination with agonists of Toll-like receptors promotes M1 (classical) activation, whereas the cytokines interleukin 4 (IL-4) and IL-13 promote M2 (alternative) activation 4, 5 . From the host-defense standpoint, M1 macrophages are inflammatory and can serve a positive role in immunity to microbial pathogens and tumors 5 . In contrast, M2 macrophages promote tissue repair and metabolic homeostasis and serve key roles in immunity to parasitic helminths 5 .
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M1 and M2 macrophages have distinct metabolic phenotypes that differ from those of resting macrophages 6, 7 . M1 macrophages rely on aerobic glycolysis, while M2 macrophages use fatty acid oxidation (FAO; also known as β-oxidation) to fuel mitochondrial oxidative phosphorylation. IL-4-induced changes in macrophage metabolism are dependent on the transcription factor STAT6 and are underpinned by induction of the expression of the nuclear receptor PPARγ coactivator PGC1β and associated mitochondrial biogenesis 8 . M2 activation is prevented by inhibition of FAO, whereas overexpression of PGC1β is sufficient to attenuate M1 activation in response to IFN-γ and lipopolysaccharide (LPS) 8 . Thus, IL-4-induced FAO is critical for M2 activation. In other cells of the immune system, FAO is known to support cellular longevity 9, 10 , but whether or not this is the case in macrophages is unclear.
Because of the health implications of the M2 activation of macrophages in various settings, there is considerable interest in understanding the cellular pathways that underpin the M2 phenotype. Despite the established importance of FAO for M2 activation, the source of the fatty acids that support this process is unknown. The consensus view from work with other cell types is that the fatty acids needed to meet metabolic and other requirements are released through a coordinated process of lipolysis from triacylglycerols stored in lipid droplets that is initiated by the enzyme adipose triglyceride lipase (ATGL) 11, 12 . However, the expression of CD36, which is a receptor for the endocytosis of triacylglycerol-rich lipoprotein particles, such as LDL and VLDL 13, 14 , is induced in macrophages by IL-4 (ref. 15 ) and has been linked to M2 activation 16 . Such findings suggested to us that the uptake and lipolysis of exogenous triacylglycerols might serve to generate fatty acids for FAO in M2 macrophages. Consistent with this view, we report here that lysosomal lipolysis mediated by lysosomal acid lipase (LAL), an enzyme that is expressed in macrophages as they differentiate from monocytes 17 and is further induced by stimulation with IL-4, has an important role in M2 activation. Inhibition of this pathway suppressed changes in oxidative phosphorylation and macrophage longevity and the expression of key genes that mark commitment to M2 activation. Many of the effects of the inhibition of lipolysis were recapitulated in CD36-deficient macrophages. Our data highlight a previously unappreciated role for LAL in cell-intrinsic lipolysis in macrophages to support FAO, show that this enzyme is integral to the M2 activation pathway and provide a framework for understanding the contribution of CD36 to these processes.
RESULTS

M2 activation depends on FAO
By extracellular flux analysis, we compared oxygen consumption by M0 (unactivated), M1 and M2 bone marrow-derived macrophages. We found that M2 macrophages had an enhanced mitochondrial oxygen-consumption rate (OCR) and markedly increased spare respiratory capacity (SRC; this is the quantitative difference between the maximal uncontrolled OCR and the initial basal OCR) 10, 18 (Fig. 1a) , indicative of increased commitment to oxidative phosphorylation. In contrast, we found no evidence of mitochondrial oxygen consumption in M1 macrophages (Fig. 1a) , which relied instead on aerobic glycolysis, measured as the extracellular acidification rate (ECAR) (Fig. 1b) , to meet their bioenergetic needs 19 . The extent of the metabolic difference between M1 cells and M2 cells was apparent in the overall ratio of oxidative phosphorylation to aerobic glycolysis, which was tenfold higher in M2 macrophages than in M1 macrophages (Fig. 1c) , reflective of polar opposite core metabolic programs. Consistent with published reports 8, 20 , we found that the commitment of M2 macrophages to FAO and oxidative phosphorylation was evident in the increased expression of genes encoding molecules in these pathways ( Supplementary Fig. 1a,c) . This commitment was also sensitive to the suppression of mitochondrial oxygen consumption by etomoxir, an inhibitor of Cpt1, a key enzyme in FAO 8 (Fig. 1d) . We found that etomoxir also eradicated SRC in M2 macrophages (Fig. 1e) , which confirmed the link between FAO and heightened oxidative phosphorylation. Enhanced SRC has been linked to longevity in memory CD8 + T cells 10 . We found such increased longevity also held true for macrophages, as M2 cells exhibited a substantial survival advantage over M0 and M1 cells in culture (Supplementary Fig. 2) .
The activation of M2 macrophages and that of M1 macrophages are marked by differences in the expression of a large panel of genes, including Mrc1 (which encodes the mannose receptor CD206), Clec10a (which encodes the C-type lectin CD301), Retlna (which encodes the effector RELMα), Pdcd1lg2 (which encodes the ligand PD-L2) and Nos2 (which encodes inducible nitric oxide synthase (iNOS)) ( Supplementary Fig. 1b,c) . By flow cytometry, we found that etomoxir substantially inhibited the expression of CD301, CD206 and RELMα in macrophages cultured in M2 conditions (Fig. 1f,g ) but had comparatively little effect on the expression of iNOS in cells cultured in M1 conditions (Fig. 1h) . Thus, FAO, measureable as increased baseline OCR and increased SRC, is essential for M2 activation.
Lipolysis contributes to M2 activation
The cellular requirements for fatty acids can be met by enzymatically regulated lipolysis of triacylglycerols into diacylglycerols and monoacylglycerols, accompanied by the release of fatty acids 11 ; an endpoint of this process is the release of glycerol from cells in which lipolysis is occurring 11 . We used mass spectrometry for global metabolite profiling and found significantly greater amounts of three of four monoacylglycerols measured in M2 cells than in M1 cells (Fig. 2a) , which indicated enhanced lipolysis in the M2 cells. Consistent with that conclusion, we found higher concentrations of extracellular glycerol in cultures of M2 macrophages than in those of M0 macrophages (Fig. 2b) . To determine whether lipolysis is linked to FAO and oxidative phosphorylation, we stimulated cells with IL-4 in the presence or absence of tetrahydrolipistatin (orlistat), a clinically used, . iNOS + cells (mean ± s.e.m.): 69.7% ± 1.3% (M1) or 60.5% ± 9.7% (M1 plus ETO). *P < 0.05 and **P < 0.0001 (Student's t-test). Data are from one experiment representative of more than three independent experiments (a-e; mean and s.e.m. (a) or mean and s.e.m. of five or more technical replicates (b-e)), one experiment representative of two experiments (f,h; mean ± s.e.m. of both) or one experiment representative of three experiments (g, left) or are from three independent experiments (g, right; mean and s.e.m.).
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VOLUME 15 NUMBER 9 SEPTEMBER 2014 nature immunology A r t i c l e s active site-directed lipase inhibitor 21 . We found that orlistat inhibited IL-4-induced increases in lipolysis, as measured by glycerol production (Fig. 2b) , and suppressed the associated changes in oxidative phosphorylation (Fig. 2c) , although it had no effect on the metabolic changes induced by M1 conditions (Fig. 2d) . These reductions in oxidative phosphorylation and SRC in orlistat-treated M2 cells were linked to significantly lower survival, evident as their decreased viability by day 2 of culture ( Fig. 2e) . Orlistat had less marked effects on the survival of M0 cells (Fig. 2e) . Within the short time frame that M1 cells remained alive, we detected no substantial effect of inhibiting lipolysis on their survival (data not shown). Given the close link between FAO and M2 activation, we next assessed the effect of inhibiting lipolysis on macrophages stimulated with IL-4. We found that orlistat suppressed the IL-4-induced expression of CD206, CD301, PD-L2 and RELMα ( Fig. 2f) but had no effect on iNOS expression in M1 macrophages (Fig. 2g) . Together these data indicated that lipolysis supported FAO and in this way was critical for M2 activation.
LAL is responsible for lipolysis upstream of FAO Our data indicated lipolysis was a critical mechanism for the generation of fatty acids for FAO and the M2 activation of macrophages stimulated with IL-4. In other cells, fatty acids for FAO are released from triacylglycerols stored in lipid droplets with cholesterol esters by a process of lipolysis that is initiated by ATGL and is continued by hormone-sensitive lipase, encoded by Pnpla2 and Lipe, respectively 11, 12, 22 . However, among genes encoding lipases, we found that Pnpla2 and Lipe had higher expression in M1 cells than in M2 cells (Fig. 3a) , which suggested that the lipases encoded by these genes might not be involved in M2 activation. To directly test this, we measured RELMα expression in peritoneal macrophages from Pnpla2 −/− mice following intraperitoneal injection of complexes of IL-4 and antibody to IL-4 (IL-4c), a procedure shown previously to induce the M2 activation of peritoneal macrophages 23 . We found that >90% of macrophages in Pnpla2 −/− mice or wild-type mice expressed RELMα following injection of IL-4c (Supplementary Fig. 3a) , which indicated that the loss of ATGL had no effect on M2 activation. A substantial body of literature has associated M1 activation with the development of lipid droplets 24 , but whether or not lipid droplets are prevalent in M2 macrophages has remained unclear. By transmission electron microscopy, we found that M1 macrophages contained easily identifiable lipid droplets, whereas M2 cells did not (Fig. 3b) . Together with the lipase-expression data and data from experiments with Pnpla2 −/− macrophages, these findings suggested that M2 macrophages were not using canonical lipid droplet-triacylglycerol hydrolysis pathways to generate fatty acids for FAO. Nevertheless, we did observe that neutral lipids (assessed by staining with the fluorescent dye BODIPY, detected by flow cytometry), lipid droplets (visualized by electron microscopy) and triacylglycerols and cholesterol esters (quantified by mass spectrometry) accumulated in macrophages stimulated with IL-4 in the presence of orlistat (Supplementary Fig. 3b-d) . Mass spectrometry additionally confirmed that neutral lipid stores were larger in M1 macrophages than in M2 macrophages ( Supplementary  Fig. 3d ). These findings indicated that M2 macrophages accumulated neutral lipid stores when lipolysis was inhibited.
We noted that unlike the expression of genes encoding many other cellular lipases (including Pnpla2, Lipe, Lipc and Lipg), expression of Lipa was upregulated in M2 macrophages relative to its expression in M1 macrophages ( Fig. 3a and Supplementary Fig. 1c) , which suggested that its product might be important for M2 activation. Lipa encodes LAL, a triacylglycerol lipase that is able to break down triacylglycerols delivered into the lysosomes by endocytosis of low-density lipoproteins (LDLs and VLDLs) 25 . Since LAL is a known target of orlistat 26 , we reasoned that the effects of orlistat on the FAO and M2 activation of macrophages we had observed (Fig. 2 ) might 
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A r t i c l e s reflect inhibition of LAL function in this system. To investigate the role of LAL (which, unlike the other cellular lipases, has optimal activity at an acidic pH rather than at a neutral pH) in M2 activation, we first neutralized lysosomal pH with chloroquine or bafilomycin A1. We found that these conditions completely inhibited the IL-4-induced increases in oxidative phosphorylation, as measured by OCR, the OCR/ECAR ratio and SRC (Fig. 3c) . These effects were accompanied by inhibition of the IL-4-induced increases in the expression of CD206, CD301, PD-L2 and RELMα (Fig. 3d) and a decrease in longevity (Fig. 3e) . These data supported the view that an acidic compartment was essential for M2 activation and were consistent with the proposal of a role for LAL in this process. To formally address this possibility, we targeted LAL with short hairpin RNA (shRNA) and found that increased oxidative phosphorylation, higher expression of CD206, CD301, RELMα and PD-L2 and increased longevity in response to IL-4 were significantly inhibited by the suppression of LAL expression ( Fig. 3f-h) . Suppression of LAL expression also resulted in the accumulation of lipid droplets in macrophages stimulated with IL-4 ( Supplementary Fig. 3b ). Additionally, we examined the ability of Lipa −/− macrophages to become M2 activated and found that increases in the expression of CD206, CD301 and RELMα were substantially attenuated in Lipa −/− macrophages relative to those in Lipa +/+ cells (Fig. 3i) . Finally, we made bone marrow chimeras by reconstituting irradiated CD45.2 + mice with CD45.1 + bone marrow that had been transduced with retrovirus encoding shRNA targeting Lipa or a control gene (encoding luciferase). We were able to distinguish the progeny of transduced cells by the expression of human coreceptor CD8 encoded as a reporter by the retrovirus. We examined the M2 activation of peritoneal macrophages derived from transduced CD45.1 + bone marrow cells and of those derived from their untransduced counterparts, following intraperitoneal injection of IL-4c into the host mice. We found that the RELMα expression of peritoneal macrophages in response to IL-4 was inhibited by the suppression of LAL expression (Fig. 3j) . Together these data indicated a critical role for cell-intrinsic lipolysis mediated by LAL in optimal M2 activation of macrophages in response to IL-4.
Optimal M2 activation depends on CD36
The importance of LAL in M2 macrophages suggested that the delivery of triacylglycerol to lysosomes is a key process in the generation of fatty acids to support FAO and M2 activation. We examined the expression of receptors that mediate the uptake of triacylglycerol-carrying npg serum lipoproteins in M2 macrophages and observed that CD36 expression was upregulated in M2 cells 15 (Fig. 4a) . The same was true for Scarb1 (which encodes the related scavenger receptor SR-B1) but not for Ldlr1, Vldlr or Lrp8 (Fig. 4a and Supplementary Fig. 1c) .
On the basis of these observations, and the fact that CD36 has been linked to M2 activation 16 , we hypothesized that CD36 might serve a role in the increased FAO in M2 macrophages by facilitating the uptake of triacylglycerols. To investigate this, we assessed the responses to IL-4 of macrophages made from the bone marrow of Cd36 −/− mice. We found that Cd36 +/+ M2 macrophages took up more LDL (Fig. 4b) and VLDL (Fig. 4c) than M0 macrophages did, but Cd36 −/− M2 macrophages did not. In addition to being a receptor for LDL and VLDL, CD36 is a fatty acid translocase 13, 14 . While we found M2 macrophages were more able to take up palmitate than were M0 cells, we observed no difference between Cd36 +/+ and Cd36 −/− cells in this uptake (Supplementary Fig. 4a ), which suggested that the fatty acid-translocase activity of CD36 did not account for the increased uptake of free fatty acids by M2 cells. Cd36 −/− macrophages exhibited significantly lower IL-4-induced increases in oxidative phosphorylation than those of Cd36 +/+ macrophages, as measured by OCR, the OCR/ECAR ratio and SRC (Fig. 4d) , but were substantially similar in terms of the metabolic markers of M1 activation (Fig. 4e) . Consistent with a critical role for FAO in M2 activation, Cd36 −/− macrophages had much lower expression of PD-L2 and RELMα in response to IL-4 than did Cd36 +/+ macrophages (Fig. 4f) . In contrast, iNOS expression was similar in Cd36 +/+ and Cd36 −/− macrophages stimulated in M1 conditions (Fig. 4g) . We further addressed the role of CD36 by inhibiting CD36 in wild-type macrophages with sulfo-N-succinimidyl oleate (SSO) and examining the effect of this inhibition on responses to IL-4 (ref. 27 ). The findings of these experiments confirmed those of our studies with Cd36 −/− macrophages. We found that LDL uptake was substantially inhibited by SSO (Supplementary Fig. 4b ). Moreover, SSO completely blocked IL-4-induced increases in oxidative phosphorylation, as measured by OCR, the OCR/ECAR ratio and SRC ( Supplementary Fig. 4c ), but had no effect on metabolic markers of M1 activation (Supplementary Fig. 4d ). SSO substantially inhibited the expression of CD206, CD301, PD-L2 and RELMα in response to IL-4 ( Supplementary Fig. 4e ) but had no effect on iNOS expression in M1 macrophages (Supplementary Fig. 4f ). Together these data supported the view that elevated CD36 expression in macrophages in response to IL-4 had an important role in increased uptake of LDL and VLDL and that this pathway supported FAO and M2 activation. Next we assessed the ability of monocyte-derived macrophages from a CD36-deficient patient to become alternatively activated in response to IL-4. We found that SRC was substantially diminished in CD36-deficient human M2 macrophages compared with that in CD36-sufficient human M2 macrophages (Fig. 4h) . Expression of CD206 (the mannose receptor MRC1) is a marker of human M2 activation, as is expression of CD36 (ref. 28 ). Thus, we used flow cytometry to examine the expression of CD36 and CD206 in M0, M1 and M2 macrophages from CD36-sufficient and CD36-deficient subjects. We found higher expression of CD36 and CD206 in M2 macrophages than in M0 or M1 macrophages and much lower expression of CD206 in CD36-deficient macrophages stimulated with IL-4 than in their CD36-sufficient counterparts (Fig. 4i) . Together with our findings from mouse Cd36 −/− macrophages and the SSO-inhibitor studies, these data from human CD36-deficient macrophages supported the proposal of a role for CD36 in M2 activation.
Our data suggested that the lysosomal lipolysis of exogenous triacylglycerols acquired through a CD36-dependent mechanism was important for optimal M2 activation. Thus, we reasoned that depriving macrophages of exogenous triacylglycerols should affect M2 activation. We cultured macrophages for 24 h in complete medium containing or lacking serum, stimulated the cells for an additional 24 h with IL-4 and measured the expression of genes encoding key M2 markers. In these experiments, M2 activation was substantially inhibited, but not prevented, by the absence of serum (Supplementary Fig. 5a ). 
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Consistent with our data indicating the involvement of CD36-mediated uptake of LDL and VLDL in M2 macrophages, we found that under serum-free conditions, M2 activation was promoted by the addition of LDL and VLDL (Supplementary Fig. 5a ). The finding that M2 activation was able to proceed to some extent in the absence of serum suggested that macrophages have an alternative pathway for fueling FAO. A candidate for such an alternative pathway is fatty acid synthesis. To explore this possibility, we examined how M2 activation was affected by TOFA, an inhibitor of acetylCoA carboxylase that catalyzes an early step in the synthesis of fatty acids from acetyl-CoA. TOFA completely blocked M2 activation in serum-free conditions and, in the presence of serum, reduced activation to levels observed in inhibitor-free, serum-free conditions (Supplementary Fig. 5b ). These data suggested that macrophages have an underlying pathway through which, in the presence of IL-4, they synthesize fatty acids to support M2 activation, and that optimal M2 activation requires contributions of exogenous triacylglycerols and newly synthesized fatty acids. The findings reported above raised the question of whether M2 macrophages first incorporate endogenously synthesized fatty acids into triacylglycerols before liberating them by lipolysis for FAO, which has been suggested to be the dominant pathway in other cell types 11 . We examined this by first assessing the effect of orlistat on M2 activation in serum-free conditions. We found that the inhibition of lipolysis under these conditions did inhibit M2 activation (Supplementary Fig. 5b) , which indicated that endogenously synthesized fatty acids were incorporated into triacylglycerols in M2 macrophages. Triacylglycerols synthesized in this way are stored as lipid droplets, but our ultrastructural analysis did not identify lipid droplets in M2 cells (Fig. 3b) . However, we did observe lipid droplets in macrophages stimulated with IL-4 in the presence of orlistat and in macrophages transduced with shRNA targeting Lipa (Supplementary Fig. 3b ). Since the inhibition of lipolysis precludes the synthesis of these neutral lipid stores from fatty acids liberated from acquired triacylglycerols, we assumed that they were produced from newly synthesized fatty acids. Together our data raised the possibility that in addition to a primary pathway in which exogenous triacylglycerols were broken down in the lysosomal compartment to support FAO, M2 macrophages were also able to synthesize triacylglycerols from newly synthesized fatty acids and hydrolyze these via the same pathway.
M2 activation during helminth infection is LAL dependent
Our data indicated that lipolysis was essential for the metabolic switch and associated changes in the expression of key genes that occurred as macrophages became alternatively activated in response to IL-4. To assess whether lipolysis was critical for M2 activation in vivo, we used the Heligmosomoides polygyrus bakeri (H. polygyrus) mouse model of human intestinal helminth infection, in which M2 macrophages have an essential role in immunity 29 . We found that the number of peritoneal macrophages increased significantly over time during this infection (Fig. 5a) and that peritoneal macrophages from infected mice exhibited the metabolic profile of IL-4-activated bone marrow macrophages, with heightened baseline OCR and considerable SRC (Fig. 5b) . Consistent with published observations 30 , a substantial frequency of peritoneal macrophages from H. polygyrus-infected mice expressed the M2 marker RELMα (Fig. 5c) . We found that maintenance of the M2-activation phenotype of peritoneal macrophages was dependent on LAL in this setting, since increases in OCR and RELMα expression were significantly inhibited in peritoneal macrophages treated ex vivo with small interfering RNA (siRNA) targeting Lipa (Fig. 5d,e) . The dependence of M2 activation on LAL was also apparent in peritoneal cells maintained in a type 2 environment through the addition of IL-4 in vitro (Fig. 5f,g ). These data indicated that macrophages in a type 2 cytokine environment in vivo exhibited lipolysis-dependent changes in metabolism and expression of genes encoding M2 markers equivalent to those induced by IL-4 in bone marrow-derived macrophages in vitro.
Inhibition of lipolysis suppresses parasite elimination
Primary infection of C57BL/6 mice with H. polygyrus is chronic despite the development of a type 2 cytokine response. However, injection of IL-4c into infected mice results in a reduction in the number of adult parasites, and M2 macrophages have been linked to the protective mechanism induced by this cytokine 3, 29, 31 . Given our findings, we reasoned that lipolysis should be crucial for the development of M2 macrophages in these settings and therefore that inhibition of this pathway would limit the expression of M2 macrophage-dependent protective immune responses. We found that injection of IL-4c after primary infection markedly enhanced the oxidative phosphorylation of peritoneal macrophages (Fig. 6a) and their RELMα expression (Fig. 6b) while simultaneously significantly reducing parasite burden, as measured by quantification of eggs and adult worms (Fig. 6c,d) . 
A r t i c l e s
Consistent with the proposal of a major role for lipolysis in M2 polarization, we found that the enhanced M2 activation and concomitant protective effects associated with the injection of IL-4c were significantly inhibited by parenteral treatment with orlistat (Fig. 6 ).
Mice in which primary H. polygyrus is cleared by chemotherapy exhibit a degree of immunity to secondary infection 29 . We compared the response of peritoneal macrophages during primary H. polygyrus infection with their response to a secondary infection after mice had cleared the parasite via administration of the anti-helminthic pyrantel pamoate and had been allowed to 'rest' for 5 weeks. We found that the number of peritoneal macrophages (Fig. 7a) and the magnitude of the increase in oxidative phosphorylation and RELMα expression (Fig. 7b,c) were all significantly greater in mice responding to the secondary infection. This correlated with resistance to secondary infection, apparent as an over 50% lower adult worm burden arising from secondary infection than from primary infection (Fig. 7d) . We then sought to determine whether inhibition of lipolysis following secondary infection affected enhanced M2 activation or resistance to secondary infection. We found that treatment with orlistat prevented the increase in the number of peritoneal macrophages that occurred during secondary infection (Fig. 7a) , inhibited all measured parameters of enhanced M2 activation (Fig. 7b,c) and suppressed the resistance to reinfection in immune mice (Fig. 7d) .
Given the experimental approach used here, there was a possibility that orlistat was affecting not only macrophage function but also adaptive immunity. To address this, we used 4get/KN2 IL-4 reporter mice to quantify CD4 + type 2 helper T cells (T H 2 cells) in mesenteric lymph nodes following primary or secondary infection with or without orlistat treatment. We found that inhibition of lipolysis during the development of the effector or secondary effector response had no measurable effect on the adaptive response, as assessed by the overall cellularity of the mesenteric lymph nodes ( Supplementary  Fig. 6a ) and the number of IL-4-secreting T H 2 cells in the mesenteric lymph nodes (Supplementary Fig. 6b) . Furthermore, examining IL-4 reporter expression in all live cells from mice treated with orlistat did not reveal any effects on non-T H 2 cell sources of IL-4 (data not shown). In summary, our data showed that inhibition of lipolysis was able to block the M2 activation of macrophages associated with resistance to the helminth parasite H. polygyrus and in so doing suppressed immunity to this pathogen.
DISCUSSION
We have shown that the enhanced FAO and related SRC in macrophages stimulated with IL-4 were dependent on a pathway of cell-intrinsic lipolysis mediated by the lysosomal enzyme LAL. Consistent with the necessity of generating fatty acids to fuel FAO and the importance of FAO for M2 activation, we found higher expression of LAL in M2 macrophages than in M1 macrophages and that this was critical for full M2 activation of macrophages in response to IL-4.
Mutations in the gene encoding LAL cause Wolman's disease and cholesterol ester-storage disease, which are characterized by varying degrees of accumulation of triacylglycerols and cholesterol esters not only in the liver, intestine and adrenal glands but also in the blood vessels and spleen. Notably, the accumulation of triacylglycerol in macrophages is associated with deficiencies in LAL activity, and atherosclerosis, a disease ameliorated by M2 activation 32, 33 , develops prematurely in cholesterol ester-`storage disease 25 . Moreover, genome-wide association studies have revealed that polymorphisms in LIPA are associated with premature human coronary artery disease with least three distinct genetic backgrounds 34, 35 . Thus, a genetic link exists between LAL and a disease in which M2 macrophages are considered to have an important protective role. The clinical evidence provides support for the possibility that LAL has an important role in the biology of M2 macrophages. Lipa −/− mice represent a model of human LAL deficiencies and have provided insight into the role of LAL in the immune system. In these mice, which die prematurely, lymphopoiesis is diminished and is accompanied by a myeloproliferative disorder and multiorgan sterile inflammation 36 that can be reversed by the macrophage-specific expression of human LAL 37 ; this supports the view that macrophage LAL has a critical role in the homeostatic control of inflammation. Such data are consistent with our finding that LAL was essential for M2 activation and the known ability of M2 activation to ameliorate inflammation in many settings. Notably, bone marrow transplantation has been used to treat Wolman's disease 38 , which supports the view that lack of LAL expression in cells of hematopoietic origin is critical for the pathogenesis of this disease.
It has been suggested that compared with M1 macrophages, which exert their functions over short time periods, M2 macrophages are engaged in activities that are more prolonged, and that the relative efficiency of FAO versus that of glycolysis is well suited to meet the metabolic requirements of these roles 7 . Consistent with this view, we found that M2 macrophages survived longer than M1 macrophages did in culture and had substantial SRC, a characteristic that in CD8 + T lymphocytes is linked to the enhanced FAO and cellular longevity of memory cells 10 . In parallel studies, LAL has also been found to be responsible for the generation of fatty acids for FAO in memory CD8 + T cells, a process that is driven by IL-15 (ref. 39) , which suggests that LAL has broadly assumed the role of coordinating increases in FAO induced by cytokines (IL-4 or IL-15) to support the longevity of cells of the immune system. Notably, the population expansion of M2 peritoneal macrophages that occurred in immune mice following challenge infection with H. polygyrus did not occur when lipolysis was inhibited. This finding may reflect reduced survival of these cells due to diminished FAO, as was apparent in orlistat-treated M2 macrophages in tissue culture. An alternative explanation is that this failure was the result of reduced proliferation of the M2 macrophage population. Reports have indicated that helminth infection-induced M2 macrophages proliferate in situ and that population expansion in these cases is driven by proliferation rather than by the recruitment and differentiation of monocytes 23, 30 . Thus, in addition to blocking the expression of genes encoding molecules associated with M2 activation, inhibition of lipolysis may also effectively block IL-4-induced macrophage proliferation, especially since fatty acids derived from the lipolysis of triacylglycerols can serve as building blocks for the synthesis of membrane lipids, which is critical in cells undergoing division. The lipolysis of triacylglycerols may also generate fatty acids that can serve as ligands for nuclear receptors such a PPARs, which regulate the expression of genes encoding molecules used for FAO and are critical for M2 activation 40 . It is feasible that inhibition of lipolysis influences macrophage fate following exposure to IL-4 by blocking these processes.
A published report has shown that IL-4 induces increased lipolysis in adipocytes by promoting hormone-sensitive lipase activity 41 . Nevertheless, we found that M2 activation associated with increased oxidative phosphorylation occurred normally in macrophages deficient in either ATGL or hormone-sensitive lipase (data not shown), which indicated that these cells used alternative pathways of lipolysis to liberate fatty acids from triacylglycerols. Our data showed that this alternative pathway was mediated by LAL, whose expression we found was higher in M2 macrophages and which has also been reported to have higher expression in human M2 macrophages than in M1 macrophages 28 . Notably, genes encoding lysosomal proteins show enrichment for STAT6 binding, as assessed by chromatin immunoprecipitation 42 , which indicates that IL-4 generally induces lysosomal function. Our data provide support for the proposal that lysosomal lipolysis of triacylglycerols is critical for optimal M2 activation and link the uptake of triacylglycerol-carrying proteins such as VLDL and LDL through CD36 to this process. Notably, we found that IL-4-induced increases in oxidative phosphorylation and expression of CD206, CD301, PD-L2 and RELMα were unaffected by deletion of Ldlr itself (data not shown). Reports have indicated that the uptake of oxidized LDL via CD36 and platelet-activating factor receptor 43 , as well as expression of the gene encoding the LDLR-related protein LRP1 (ref. 44) , are sufficient to promote IL-4-independent expression of certain genes linked to the M2 phenotype, although the mechanisms underlying these effects are unclear. Moreover, the neutral cholesterol esterase hydrolases encoded by Nceh1 and Ces1g have been linked to the ability of macrophages to serve an anti-inflammatory role in atherosclerosis 45, 46 , and expression of both of these genes, as well as of Lrp1, was somewhat elevated after stimulation with IL-4.
Our findings suggest that in addition to fueling FAO through the lipolysis of exogenous triacylglycerols, M2 macrophages can utilize endogenous triacylglycerols, generated from newly synthesized fatty acids, for the same purpose. We believe that these endogenously synthesized triacylglycerols contributed to the formation of lipid droplets in M2 cells in which lipolysis had been inhibited. On balance, the data indicate that the lipolysis of endogenously synthesized triacylglycerols is also mediated by LAL, since suppression of LAL expression in M2 cells also resulted in the accumulation of lipid droplets. It is unclear at present how LAL gains access to lipid droplets in M2 macrophages. In other non-adipocyte cells, lysosome-dependent autophagy has been reported to be important for the lipolysis of triacylglycerols in lipid droplets 47, 48 . We have not found evidence to support the existence of this pathway in M2 macrophages cultured in complete medium (data not shown), but it is feasible that autophagy programs are engaged when access to fatty acids from exogenous triacylglycerols is restricted. However, autophagy-independent lysosomal lipolysis of lipid droplets by macrophages is not unprecedented 49 , so it remains feasible that the lipolysis of endogenously synthesized triacylglycerols occurs through as-yet-unknown mechanisms.
M2 macrophages have important roles in immune responses to helminth parasites, acting to directly affect parasite health and persistence in sites of infection and/or to regulate T cell responses and associated immunopathology. Through the use of two models of elimination of the intestinal helminth parasite H. polygyrus by the immune system, we found that inhibition of lipolysis significantly diminished antiparasitic immunity promoted by the injection of IL-4 into mice carrying a primary infection and inhibited resistance to secondary infection in mice challenged after a drug-induced cure of the primary infection. In both cases, reductions in immunity were tightly correlated with decreases in oxidative phosphorylation and the expression of M2 markers in peritoneal macrophages. We found no evidence of an effect of inhibiting lipolysis on T H 2 cell responses, which indicated that the observed differences in immunity were probably not linked to reductions in the production of type 2 effector cytokines by the adaptive response, although we have not formally ruled out the possibility of an effect on other sources of IL-4 or IL-13. We infer from these findings that lipolysis has a role in M2 activation in vivo in the setting of helminth infection. There have been no reports to our knowledge of a role for LAL in immunity to parasitic helminths in mice or humans, but the latter may reflect the relative lack of genome-wide association studies to identify quantitative trait loci encoding molecules that affect human resistance to helminth parasites. Collectively, our data indicate that macrophages use the lysosomal pathway to mobilize fatty acids to facilitate FAO and the M2 activation program. Our findings suggest that approaches for gain or loss of function of LAL may offer therapeutic potential in diseases in which M2 macrophages have protective or detrimental effects.
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